Name : PRAM1 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN3827281903
| Long name | PRAM1 Primary Polyclonal Antibody |
| Also known as | PRAM1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | PRAM1 |
| Specificity | This is a highly specific antibody against PRAM1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human PRAM1 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | PRAM-1 (PML-RAR-a target gene encoding an adaptor molecule 1) encodes an adaptor protein which is expressed and modulated during normal human myelopoiesis, PRAM-1 demonstrates expression in hematopoietic tissues and lung, PRAM-1 expression is hindered by expression of PML-RAR-a, The 718 amino acid PRAM-1 protein contains eight N-terminal proline-rich repeats and several proline residues that are clustered as type I or type II SH3 recognition motifs, The retinoic acid-induced gene, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia cells, Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | PML RARA regulated adaptor molecule 1, PML RARA target gene encoding an Adaptor Molecule 1, PML-RARA-regulated adapter molecule 1, PRAM, PRAM 1, PRAM-1, PRAM1, PRAM_HUMAN, PML RAR |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | PRAM1 |
| Short name | PRAM1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | alpha regulated adaptor molecule 1 (Antibody to), promyelocytic leukemia-retinoic acid receptor |
| Alternative technique | antibodies |
| Alternative to gene target | PRAM1 and IDBG-24943 and ENSG00000133246 and 84106, PRAM1 and IDBG-643837 and ENSBTAG00000021041 and 504848, Pram1 and IDBG-167526 and ENSMUSG00000032739 and 378460, lipid binding, multiple, this GO :0005515 and protein binding and molecular function this GO :0007229 and integrin-mediated signaling pathway and biological process this GO :0008289 and lipid binding and molecular function this GO :0043313 and regulation of neutrophil degranulation and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008289: lipid binding, this GO :0008289: lipid binding, PML-RARA regulated adaptor molecule 1 |
| Identity | 30091 |
| Gene | PRAM1 |
| Long gene name | PML-RARA regulated adaptor molecule 1 |
| Synonyms | PML-RAR |
| Locus | 19p13, 2 |
| Discovery year | 2005-07-04 |
| GenBank acession | BC028012 |
| Entrez gene record | 84106 |
| Pubmed identfication | 11301322 15572693 |
| RefSeq identity | NM_032152 |
| Havana BLAST/BLAT | OTTHUMG00000167924 |